Related Experiment Video
Updated: Jul 13, 2025

A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice
Published on: October 13, 2018
A Improving Birth-dose Hepatitis-B Vaccination in a Tertiary Level IV Neonatal Intensive Care Unit
Indirapriya Avulakunta1, Palanikumar Balasundaram2, Alma Rechnitzer3
1From the Division of Neonatology, Department of Pediatrics, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock, Ark.
Insights
A quality improvement initiative successfully increased Hepatitis B vaccine (HBV) rates in a neonatal intensive care unit (NICU). Eligible infants received timely HBV immunization, improving public health outcomes.
Area of Science:
- Public Health
- Immunization Practices
- Neonatal Care
Background:
- Perinatal hepatitis B is a significant global health issue.
- Hepatitis B vaccine (HBV) is recommended for infants within 24 hours of birth.
- Infants in neonatal intensive care units (NICUs) often missed timely HBV vaccination.
Purpose of the Study:
- To implement a quality improvement (QI) initiative to increase birth dose HBV immunization rates in a level IV NICU.
- To address missed HBV vaccinations in NICU infants weighing over 2000g.
- To improve timely HBV administration for eligible neonates.
Main Methods:
- A multidisciplinary QI team identified barriers using an Ishikawa cause-and-effect diagram.
- Interventions included enhanced collaboration, EMR reminders, education, and improved communication.
- Four Plan-Do-Study-Act cycles were conducted over 19 months.
Main Results:
- The rate of birth dose HBV administration within 12 hours increased from 24% to 56%.
- The rate within 24 hours improved from 31% to 64%.
- Process measure compliance exceeded the 25% improvement target and demonstrated sustained results.
Conclusions:
- The QI initiative effectively improved timely HBV administration for eligible infants in the NICU.
- This initiative can serve as a model for other institutions to enhance HBV immunization rates.
- Improved vaccination rates contribute to reducing perinatal hepatitis B transmission.
Background:
Perinatal hepatitis B is a global public health concern. To reduce perinatal hepatitis B and its complications, the Hepatitis B vaccine (HBV) is recommended by the New York State Department of Health and Advisory Committee on Immunization Practices within 24 hours of life for infants born with a birth weight ≥2000 g. Infants admitted to the neonatal intensive care unit (NICU) weighing over 2000 g missed their birth dose HBV frequently, which prompted the implementation of a quality improvement initiative to increase birth dose HBV immunization in a level IV NICU in New York.
Methods:
May 2019 to April 2021 baseline data showed the birth dose HBV rate of infants born ≥2000 g at 24% and 31% within 12 and 24 hours, respectively. The multidisciplinary QI team identified barriers using an Ishikawa cause-and-effect diagram. Our interventions included multidisciplinary collaboration, electronic medical record reminders, education, posters, and improved communication between staff and parents. We aimed to achieve a 25% improvement from the baseline.
Results:
After 19 months of QI interventions (four Plan-Do-Study-Act cycles), the rate of administering birth dose HBV within 12 hours of life increased from 24% to 56% and within 24 hours from 31% to 64%. Process measure compliance improved, exceeding the 25% target, and showed sustained improvement.
Conclusion:
This QI initiative improved the rate of eligible infants receiving HBV within the first 24 hours of life in the NICU. This work can serve as a model for other healthcare institutions to improve HBV immunization rates in NICUs.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Factors Affecting Drug Response: Overview

